Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

9.7K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

625
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
625
Subviral Agents01:29

Subviral Agents

53
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
53
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

549
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
549
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease Knowledge.

Journal of personalized medicine·2026
Same author

The impact of oxidative stress on symptoms associated with multiple sclerosis.

Scientific reports·2025
Same author

Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumab.

Frontiers in pharmacology·2025
Same author

Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple Sclerosis.

Patient preference and adherence·2025
Same author

Pharmacogenetics of siponimod: A systematic review.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022
Same author

Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.

Neurology(R) neuroimmunology & neuroinflammation·2021

Related Experiment Video

Updated: Aug 1, 2025

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.0K

[Human prion diseases: An overview].

Raquel Piñar-Morales1, Francisco Barrero-Hernández1, Luis Aliaga-Martínez2

  • 1Departamento de Medicina, Facultad de Medicina, Universidad de Granada, Granada, España; Servicio de Neurología, Hospital Clínico San Cecilio, Granada, España.

Medicina Clinica
|April 23, 2023
PubMed
Summary
This summary is machine-generated.

Prion diseases are fatal neurodegenerative conditions caused by misfolded proteins. Early diagnosis using tools like MRI and RT-QuIC is crucial for patient care and infection control, despite no current cure.

Keywords:
Creutzfeldt–Jakob diseaseEnfermedad de Creutzfeldt-JakobEnfermedad priónicaFatal familial insomniaGerstmann-Sträussler-Scheinker syndromeInsomnio familiar fatalPrionPrion diseasesReal-time quaking-induced conversion (RT-QuIC)Síndrome de Gerstmann-Sträussler-Scheinker

More Related Videos

Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

802
Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

528

Related Experiment Videos

Last Updated: Aug 1, 2025

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.0K
Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

802
Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

528

Area of Science:

  • Neurology
  • Protein misfolding diseases
  • Neurodegenerative disorders

Background:

  • Prion diseases are fatal neurodegenerative conditions.
  • Caused by misfolded prion proteins (PrPSc) that propagate by inducing normal prion proteins (PrP) to misfold.
  • Acquired sporadically, genetically, or through infection (dietary or iatrogenic).

Purpose of the Study:

  • To highlight the challenges in diagnosing prion diseases.
  • To emphasize the importance of early diagnosis for patient management.
  • To discuss current diagnostic tools and their role.

Main Methods:

  • Review of prion disease characteristics and transmission.
  • Discussion of diagnostic modalities including Magnetic Resonance Imaging (MRI) and Real-Time Quaking-Induced Conversion (RT-QuIC).
  • Mention of neuropathological examination for definitive diagnosis.

Main Results:

  • Prion diseases present diagnostic challenges.
  • Sensitive tools like MRI and RT-QuIC show promise in aiding diagnosis.
  • Neuropathology remains the gold standard for confirmation.

Conclusions:

  • Early diagnosis of prion diseases is critical for patient care planning, infection control, and genetic counseling.
  • Despite the lack of curative treatments, timely diagnosis significantly impacts management strategies.
  • Ongoing research into diagnostic tools is essential for improving patient outcomes.